The effects of camicinal, a novel motilin agonist, on gastro-esophageal function in healthy humans-a randomized placebo controlled trial

Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society
R HobsonG E Dukes

Abstract

A proportion of patients with foregut dysmotility fail to respond to standard interventions. Motilin agonists may be beneficial in this group. We aimed to determine the effect of camicinal, a novel motilin agonist, on gastrointestinal physiology in healthy volunteers. Healthy male subjects were randomly assigned to receive a single dose of 125 mg camicinal or placebo in a double-blind cross-over design. Esophageal function and reflux indices were assessed using high-resolution manometry (pre and 1.5-h post dose) and 24-h ambulatory multichannel intraluminal impedance/pH. After a standardized meal, subjects ingested a wireless motility capsule from which compartmental transit times and motility indices were derived. Subjects were restudied with the alternate intervention after 7 days. The study subjects (12 male, mean age 47.4 years, range 22-55) tolerated the drug well, except one who exhibited mild abdominal pain on both placebo and camicinal. In comparison to placebo, gastric emptying time (GET) was accelerated following camicinal (-115.4 min, 95% confidence interval -194.4, -36.4, p = 0.009). No effect was demonstrable on esophageal function, small bowel, colonic, or whole bowel transit times and motility indices. With camic...Continue Reading

Associated Clinical Trials

References

Mar 1, 1992·Gut·S M Catnach, P D Fairclough
Aug 1, 1986·Digestive Diseases and Sciences·C M BrophyA T Taylor
Nov 1, 1996·Current Opinion in Rheumatology·R W Sjogren
Feb 20, 2003·Digestion·Thomas L AbellGervais Tougas
Dec 21, 2005·Basic & Clinical Pharmacology & Toxicology·Thierry Piche, Jean Paul Galmiche
Apr 26, 2006·The American Journal of Gastroenterology·Rosario CuomoJan Tack
Nov 22, 2007·The American Journal of Gastroenterology·Thomas L AbellUNKNOWN American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
Jan 16, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D CassillyH P Parkman
Feb 9, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·G J Sanger, D H Alpers
Feb 22, 2008·Journal of Nuclear Medicine Technology·Thomas L AbellUNKNOWN American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
Mar 28, 2008·Journal of Clinical Gastroenterology·Peter J KahrilasJohn E Pandolfino
Dec 10, 2009·Digestive Diseases and Sciences·Annapurna Korimilli, Henry P Parkman
May 11, 2010·Expert Opinion on Pharmacotherapy·David A Johnson, Benjamin H Levy
Feb 24, 2012·Alimentary Pharmacology & Therapeutics·J TackV Stanghellini
Aug 4, 2012·Current Opinion in Pharmacology·Gareth J Sanger
Aug 10, 2012·British Journal of Hospital Medicine·Adam D FarmerQasim Aziz
Oct 24, 2013·Expert Opinion on Drug Safety·Sheila A Doggrell, Jules C Hancox
May 8, 2014·World Journal of Gastroenterology : WJG·Adam D FarmerAnthony R Hobson
Jun 12, 2014·United European Gastroenterology Journal·Adam D FarmerAnthony R Hobson

❮ Previous
Next ❯

Citations

Oct 12, 2016·Current Treatment Options in Gastroenterology·William L Hasler
Jan 28, 2017·Expert Opinion on Investigational Drugs·Gareth J Sanger, Pankaj Jay Pasricha
Sep 16, 2017·Current Treatment Options in Gastroenterology·Jonathan GotfriedRon Schey
Aug 7, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·E DelooseJ Tack
Aug 1, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A-M L WegebergS M Scott
Sep 2, 2016·F1000Research·Klaus BielefeldtSalman Nusrat
Apr 22, 2017·Current Gastroenterology Reports·Carolina Malagelada, Juan R Malagelada
Sep 10, 2017·Current Gastroenterology Reports·Eamonn M M Quigley
Jan 25, 2019·Nature Reviews. Endocrinology·Eveline DelooseJan Tack
Feb 23, 2020·Current Gastroenterology Reports·Zorisadday Gonzalez, Richard McCallum
Jan 15, 2021·Current Treatment Options in Oncology·Janet Hardy, Mellar P Davis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.